CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

July 29, 2024 11:57 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will present a poster at the 4th Annual mRNA-based Therapeutics Summit taking place July 29 - 31, 2024, in Boston. The poster presents the Company's Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase - as a solution to enable mRNA producers to...

Read more

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

July 29, 2024 11:10 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will present a poster at the 4th Annual mRNA-based Therapeutics Summit taking place July 29 - 31, 2024, in Boston. The poster presents the Company's Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase - as a solution to enable mRNA producers to...

Read more

Physiowell's Holistic Path to Wellness: Empowering Everybody

July 29, 2024 10:45 AM

DUBAI, UAE / ACCESSWIRE / July 29, 2024 / It's difficult to remain current with your health and wellness journey amidst today's fast-moving world. Fortunately, Physiowell delivers a complete and holistic health approach, which empowers every individual toward the attainment of maximum well-being. In offering a range of therapies while dispensing tailored care, Physiowell gives every person the essential resources to succeed both physically and...

Read more

New Research Supports PillSafe’s Methodology in Reducing the Risk of Medication Misuse and Overuse

July 29, 2024 10:00 AM

The study raises concerns that overprescribing medications and the resulting unused medication are drivers of opioid misuse.EDMOND, OK / ACCESSWIRE / July 29, 2024 / In light of recent research published in the Canadian Medical Association Journal, PillSafe's smart pill delivery system targets the critical issues of unused prescriptions and patient medicine compliance, which the study identifies as key factors driving opioid misuse. This...

Read more

IntoValue, Inc Welcomes Brian Marcotte to Board of Directors

July 29, 2024 9:00 AM

IntoValue, Inc, proudly announces the appointment of Brian Marcotte to its Board of Directors.WASHINGTON, DC / ACCESSWIRE / July 29, 2024 / IntoValue, Inc, a groundbreaking healthcare direct-to-employer technology enablement company, proudly announces the appointment of Brian Marcotte to its Board of Directors. IntoValue logo for IntoValue Brian Marcotte brings a wealth of executive leadership experience to IntoValue, having served as President...

Read more

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

July 29, 2024 8:45 AM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the second quarter 2024 after the close of trading on Thursday, August 8, 2024. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.To join the call by telephone,...

Read more

NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge

July 29, 2024 7:00 AM

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / July 29, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical company. and Kadimastem Ltd ("KDST.TA", "Kadimastem"), a clinical-stage cell therapy company developing and manufacturing "off-the-shelf" allogeneic cell products for the treatment of neurodegenerative diseases and potential cure of diabetes, announced today that they have entered into a binding term sheet...

Read more

Intraoral Scanner Market Is Expected to Reach USD 1,548.0 Million by 2034 And Grow at A CAGR of 7.6% | Future Market Insights, Inc.

July 29, 2024 6:00 AM

The intraoral scanner market size is poised to cross USD 744.7 million in 2024 and is likely to attain a valuation of USD 1,548.0 million by 2034. The intraoral scanner industry is projected to thrive at a CAGR of 7.6% from 2024 to 2034.Robot-assisted intraoral scanners, which employ robotic arms or automated positioning devices, improve scanning precision while reducing human variability. This development indicates a shift toward more...

Read more

Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation

July 29, 2024 2:00 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO), the clinical-stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to announce its participation in the 6th Macrophage-Directed Therapies Summit ("Summit"), which will be held on October 1-3, 2024, in Boston, MA. The Company will present its work on its proprietary Chimeric Bait Receptor ("CBR") platform.The Company's...

Read more

International OCD Foundation Honors Reality Star Scheana Shay for Raising OCD Awareness

July 28, 2024 7:15 PM

ORLANDO, FL / ACCESSWIRE / July 28, 2024 / Reality television sensation Scheana Shay received international accolades Saturday, July 27, for her advocacy in raising awareness about postpartum obsessive compulsive disorder (OCD), winning the International OCD Foundation (IOCDF) Illumination Award. The IOCDF Illumination Award honors media personalities who have represented OCD in a respectful, accurate, and appropriate way, or who have challenged...

Read more

Jolt Health Inc. Financing Update

July 26, 2024 5:00 PM

VANCOUVER, BC / ACCESSWIRE / July 26, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announced that there was an error in the press release issued July 25, 2024. The Company will be issuing a total of 83,333,333 units at a price of $0.006 per unit, not 583,333,333 units as previously stated.About Jolt Health Inc.Jolt Health Inc. (CSE:JOLT) is a leading life sciences company focused on healthcare, biotechnology and...

Read more

Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

July 26, 2024 2:00 AM

LONDON, UK / ACCESSWIRE / July 26, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it is voluntarily delisting its ordinary shares ("Ordinary Shares") from trading on the OTCQB Market due to low trading volume and the associated administrative...

Read more

Jolt Health Inc. Announces Financing

July 25, 2024 5:00 PM

VANCOUVER, BC / ACCESSWIRE / July 25, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announced it is undertaking a non-brokered private placement of up to $500,000. The Company will issue up to 583,333,333 units at a price of $0.006 per unit. Each unit consists of one common share and one half of a common share warrant. Each whole warrant entitles the holder to subscribe for one additional common share for a period of...

Read more

Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

July 25, 2024 2:45 PM

CHICAGO, IL / ACCESSWIRE / July 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly-owned subsidiary, Decahedron Ltd ("Decahedron"), has...

Read more

Dr. Gilbert Lee Wins 'Top Doc' Award for 16th Consecutive Year

July 25, 2024 12:00 PM

SAN DIEGO, CA / ACCESSWIRE / July 25, 2024 / Gilbert Lee, MD, FACS, a triple board-certified plastic surgeon and founder of Changes Plastic Surgery & Spa, has again been voted one of San Diego's Physicians of Exceptional Excellence, more commonly known as San Diego's ‘Top Doctor Award' in Plastic Surgery, for the 16th consecutive year. In an annual poll conducted by the San Diego County Medical Society, local physicians are asked to nominate...

Read more

Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

July 25, 2024 11:40 AM

CHICAGO, IL / ACCESSWIRE / July 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has signed a distribution agreement (the "Agreement") with ProMed...

Read more

Smile Digital Health Named in New Gartner Report

July 25, 2024 10:30 AM

The Gartner® report How Clinical Data Integration Improves U.S. Healthcare Payer Interoperability is available now.TORONTO, ON / ACCESSWIRE / July 25, 2024 / Smile Digital Health (Smile), a leading Fast Healthcare Interoperability Resources (FHIR®) health data platform and exchange solutions provider, has been named as a Representative Repository Vendor in the report How Clinical Data Integration (CDI) Improves U.S. Healthcare Payer...

Read more

Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans

July 25, 2024 9:45 AM

10-year strategy to advance access to our innovative treatments and help patients in low- and middle-income countries (LMICs)NORTHAMPTON, MA / ACCESSWIRE / July 25, 2024 / At BMS, our vision to transform patients' lives through science extends to all patients. That is why we have a long-standing commitment to promote health equity and help people in underserved communities access the care and medicines they need.We built on this commitment with...

Read more

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference

July 25, 2024 9:05 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its abstract has been selected for poster presentation at the 2024 SNO/ASCO CNS Cancer Conference being held August 8-10, 2024 in Denver, CO.Details of the presentation are as follows:Title: Use of a...

Read more

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

July 25, 2024 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the signing of a five-year license and commercialization agreement for its CertainT® traceability platform (the "Agreement") with Indus Group ("Indus") a multinational apparel/textile manufacturing and sourcing company with a reputation for cutting-edge fabric technology and product innovation. Indus consumes...

Read more